5AM Ventures V, L.P. is 10% Owner at Entrada Therapeutics, Inc. (TRDA). They have made 5 open-market trades across 3 companies since 2021, most recently 2026-08-07.
CIK 0001674324
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RLYB | 1,335,637 | $22.0M |
| TRDA | 2,783,781 | $12.2M |
| CABA | 1,989,575 | $2.8M |
| Total | $37.0M |
Shares reported on the most recent Form 4, priced at the 2026-08-10 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 40% | — |
| Avg Move | +2.4% | +0.0% | — |
| Scored | 5 | 5 | 3 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TRDA | SELL | 2026-08-06 | 2026-08-10 | $6.88 | $432K | +8.1% | +1.3% | — |
| TRDA | SELL | 2026-07-30 | 2026-08-03 | $6.93 | $807K | +0.8% | -1.1% | — |
| TRDA | SELL | 2025-11-14 | 2025-11-18 | $8.80 | $1.8M | +13.6% | +25.7% | +26.4% |
| RLYB | SELL | 2022-02-08 | 2022-02-10 | $13.05 | $2.7M | -17.7% | -29.3% | -30.5% |
| CABA | SELL | 2021-09-07 | 2021-09-09 | $9.70 | $6.1M | +7.3% | +3.5% | +9.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.